EDUCATION

Medical School

  • Boston University School of Medicine , 1982 , Boston , MA

Internship

  • Babies Hospital , 1983 , New York , NY

Residency

  • Babies Hospital , 1985 , New York , NY

Fellowship

  • Boston Children's Hospital , 1989 , Boston , MA

CERTIFICATIONS

  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Pediatric Rheumatology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Th1 polarization defines the synovial fluid T cell compartment in oligoarticular juvenile idiopathic arthritis. JCI Insight. 2021 Sep 22; 6(18). View abstract
  2. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2021 08; 73(8):1088-1105. View abstract
  3. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2021 08; 73(8):1366-1383. View abstract
  4. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol. 2021 08; 73(8):1349-1365. View abstract
  5. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Rheumatol. 2021 08; 73(8):1384-1393. View abstract
  6. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. Arthritis Care Res (Hoboken). 2021 08; 73(8):1061-1070. View abstract
  7. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Care Res (Hoboken). 2021 08; 73(8):1071-1087. View abstract
  8. A multidisciplinary assessment of pain in juvenile idiopathic arthritis. Semin Arthritis Rheum. 2021 Aug; 51(4):700-711. View abstract
  9. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. Pediatr Rheumatol Online J. 2021 Mar 17; 19(1):31. View abstract
  10. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021 01 23; 72(1):e1-e48. View abstract
  11. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis. 2021 01 23; 72(1):1-8. View abstract
  12. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3. View abstract
  13. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Neurology. 2021 02 09; 96(6):262-273. View abstract
  14. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Arthritis Care Res (Hoboken). 2021 01; 73(1):1-9. View abstract
  15. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Arthritis Rheumatol. 2021 01; 73(1):12-20. View abstract
  16. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950. View abstract
  17. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252. View abstract
  18. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. JCI Insight. 2020 03 26; 5(6). View abstract
  19. Posterior-onset Rasmussen's encephalitis with ipsilateral cerebellar atrophy and uveitis resistant to rituximab. Epilepsy Behav Rep. 2020; 14:100360. View abstract
  20. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2020 02; 79(2):225-231. View abstract
  21. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319. View abstract
  22. Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. Neurol Neuroimmunol Neuroinflamm. 2019 05; 6(3):e560. View abstract
  23. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J. 2019 Feb 14; 17(1):7. View abstract
  24. Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2. J Allergy Clin Immunol. 2018 10; 142(4):1363-1365.e8. View abstract
  25. Association Between Dose of Glucocorticoids and Coronary Artery Lesions in Kawasaki Disease. Arthritis Care Res (Hoboken). 2018 07; 70(7):1052-1057. View abstract
  26. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. Pediatr Rheumatol Online J. 2017 Jun 13; 15(1):50. View abstract
  27. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores. J Am Heart Assoc. 2017 May 31; 6(6). View abstract
  28. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA. Clin Rheumatol. 2017 Feb; 36(2):413-419. View abstract
  29. Evidence-based decision support for pediatric rheumatology reduces diagnostic errors. Pediatr Rheumatol Online J. 2016 Dec 13; 14(1):67. View abstract
  30. Clarifying the Role of Corticosteroids in Kawasaki Disease. JAMA Pediatr. 2016 12 01; 170(12):1140-1142. View abstract
  31. Kawasaki Disease at 50 Years. JAMA Pediatr. 2016 11 01; 170(11):1093-1099. View abstract
  32. Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA. Clin Rheumatol. 2016 Nov; 35(11):2749-2756. View abstract
  33. Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2016 07; 68(7):1758-68. View abstract
  34. Kawasaki disease. Rheum Dis Clin North Am. 2015; 41(1):63-73, viii. View abstract
  35. Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J Am Heart Assoc. 2014 Nov 07; 3(6):e001483. View abstract
  36. Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study. Pediatr Rheumatol Online J. 2014; 12:39. View abstract
  37. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. J Rheumatol. 2014 Jun; 41(6):1163-70. View abstract
  38. A119: deep sequencing analysis of the T regulatory and T effector repertoire in juvenile idiopathic arthritis. Arthritis Rheumatol. 2014 Mar; 66 Suppl 11:S156. View abstract
  39. Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study. Pediatr Rheumatol Online J. 2013 Nov 01; 11(1):42. View abstract
  40. Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease. EMBO Mol Med. 2013 Feb; 5(2):210-20. View abstract
  41. Pediatric chronic nonbacterial osteomyelitis. Pediatrics. 2012 Nov; 130(5):e1190-7. View abstract
  42. Paediatric rheumatic disease: Classification warfare. Nat Rev Rheumatol. 2012 Oct; 8(10):570-2. View abstract
  43. Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis Rheum. 2012 Sep; 64(9):3025-33. View abstract
  44. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial. Lupus. 2012 Nov; 21(13):1433-43. View abstract
  45. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012 Jun; 64(6):2012-21. View abstract
  46. Putting collagen back in the collagen vascular disorders. Rheumatology (Oxford). 2011 Dec; 50 Suppl 5:v60-2. View abstract
  47. Primary lyme arthritis of the pediatric hip. J Pediatr Orthop. 2011 Oct-Nov; 31(7):787-90. View abstract
  48. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr. 2011 Apr; 158(4):644-649.e1. View abstract
  49. Musculoskeletal causes of pediatric chest pain. Pediatr Clin North Am. 2010 Dec; 57(6):1385-95. View abstract
  50. Outcomes of children treated for Lyme arthritis: results of a large pediatric cohort. J Rheumatol. 2010 May; 37(5):1049-55. View abstract
  51. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010 Feb; 125(2):e234-41. View abstract
  52. Atypical and incomplete Kawasaki disease. Best Pract Res Clin Rheumatol. 2009 Oct; 23(5):689-97. View abstract
  53. Editorial: Do no harm--first but not only. Curr Opin Rheumatol. 2009 Sep; 21(5):531-2. View abstract
  54. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009 Jul; 124(1):1-8. View abstract
  55. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum. 2009 Jun; 60(6):1825-1830. View abstract
  56. MRI findings of juvenile psoriatic arthritis. Skeletal Radiol. 2008 Nov; 37(11):987-96. View abstract
  57. Chronic minocycline-induced autoimmunity in children. J Pediatr. 2008 Sep; 153(3):314-9. View abstract
  58. Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Rheum. 2008 Jan 15; 59(1):51-8. View abstract
  59. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40. View abstract
  60. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics. 2007 Sep; 120(3):503-8. View abstract
  61. Vasculitis in children. Rheum Dis Clin North Am. 2007 Aug; 33(3):555-83. View abstract
  62. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. J Pediatr. 2007 Apr; 150(4):376-82. View abstract
  63. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75. View abstract
  64. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol. 2007; 8(12):R261. View abstract
  65. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum. 2006 Dec; 54(12):3971-8. View abstract
  66. Patients with juvenile psoriatic arthritis comprise two distinct populations. Arthritis Rheum. 2006 Nov; 54(11):3564-72. View abstract
  67. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun. 2005 Aug; 6(5):438-44. View abstract
  68. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics. 2005 Jul; 116(1):e89-93. View abstract
  69. MRI features of Lyme arthritis in children. AJR Am J Roentgenol. 2005 Jun; 184(6):1904-9. View abstract
  70. Vasculitis in children. Pediatr Clin North Am. 2005 Apr; 52(2):547-75, vii. View abstract
  71. Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study. J Pediatr. 2004 Dec; 145(6):856-7. View abstract
  72. Rituximab therapy for multisystem autoimmune diseases in pediatric patients. J Pediatr. 2003 Nov; 143(5):598-604. View abstract
  73. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr. 2003 Jun; 142(6):611-6. View abstract
  74. A clinical practice guideline for treatment of septic arthritis in children: efficacy in improving process of care and effect on outcome of septic arthritis of the hip. J Bone Joint Surg Am. 2003 Jun; 85(6):994-9. View abstract
  75. Raynaud's phenomenon in children: a retrospective review of 123 patients. Pediatrics. 2003 Apr; 111(4 Pt 1):715-21. View abstract
  76. Physical and psychosocial health in children who have had Kawasaki disease. Pediatrics. 2003 Mar; 111(3):579-83. View abstract
  77. Update on the treatment of Kawasaki disease in childhood. Curr Rheumatol Rep. 2002 Dec; 4(6):474-82. View abstract
  78. Fibroblastic rheumatism: case report and review of the literature. Pediatr Dermatol. 2002 Nov-Dec; 19(6):532-5. View abstract
  79. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol. 2002 Oct; 47(4):505-11. View abstract
  80. Vasculitis in childhood. Rheum Dis Clin North Am. 2002 Aug; 28(3):625-54. View abstract
  81. Prolonged sensory and motor deficit following short-term lumbar epidural analgesia in a patient with mixed connective tissue disease. J Pain Symptom Manage. 2002 Feb; 23(2):89-92. View abstract
  82. Vasculitis in childhood. Curr Opin Rheumatol. 2001 Sep; 13(5):422-7. View abstract
  83. Treatment of TRAPS with etanercept: use in pediatrics. Clin Exp Rheumatol. 2001 Jul-Aug; 19(4):484-5. View abstract
  84. Aortic root dilation in Kawasaki disease. Am J Cardiol. 2001 Apr 01; 87(7):919-22. View abstract
  85. Psoriatic eruption in Kawasaki disease. J Pediatr. 2000 Oct; 137(4):578-80. View abstract
  86. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. Pediatrics. 2000 May; 105(5):E64. View abstract
  87. Report of the National Institutes of Health Workshop on Kawasaki Disease. J Rheumatol. 1999 Jan; 26(1):170-90. View abstract
  88. Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol. 1998 Nov; 26(5):365-9. View abstract
  89. Outcomes of children treated for Lyme disease. J Rheumatol. 1998 Nov; 25(11):2249-53. View abstract
  90. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998 Aug; 133(2):254-8. View abstract
  91. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol. 1998 May 01; 81(9):1116-20. View abstract
  92. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. J Rheumatol. 1996 May; 23(5):919-24. View abstract
  93. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996 Jan; 128(1):146-9. View abstract
  94. Osteomyelitis and septic arthritis in children: appropriate use of imaging to guide treatment. AJR Am J Roentgenol. 1995 Aug; 165(2):399-403. View abstract
  95. Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor. J Immunol. 1994 May 01; 152(9):4680-5. View abstract
  96. Kawasaki disease and its cardiac sequelae. Hosp Pract (Off Ed). 1993 Nov 15; 28(11):51-4, 57-60, 64-6. View abstract
  97. Gamma globulin re-treatment in Kawasaki disease. J Pediatr. 1993 Oct; 123(4):657-9. View abstract
  98. Kawasaki disease and acute renal failure. Pediatr Nephrol. 1993 Oct; 7(5):593. View abstract
  99. Audiologic profiles of children with Kawasaki disease. Am J Otol. 1992 Nov; 13(6):512-5. View abstract
  100. Decreased protein binding of salicylates in Kawasaki disease. J Pediatr. 1991 Mar; 118(3):456-9. View abstract
  101. Sensorineural hearing loss associated with Kawasaki disease. J Pediatr. 1990 Sep; 117(3):371-7. View abstract
  102. Kawasaki disease. Curr Opin Rheumatol. 1990 Feb; 2(1):81-6. View abstract